Behind the scenes

what

AIDA aims to develop and validate a multidisciplinary AI-powered assistant that will support clinicians in gastric cancer prevention by diagnosing precancerous gastric-inflammation and suggesting personalised therapeutics and monitoring.

how

We envision a new form of collaboration, beyond the public-private partnership model, in which participants from different countries or sectors exchange their data to create public value.

Data collaboratives form a sustainable answer to the problem that collaborative research and clinical innovation are generally limited to local, fragmented of limited quality, and research is progressing through ad-hoc collaborations on specific projects.

why

The Sooner. The Better.

Most cases of gastric cancer are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing gastric cancer at the pre-symptomatic stage, typically chronic infection with H. pylori, could significantly improve the outlook.

Spread the word!

In order to make our research accessible to everyone, you can easily download a free documentation of AIDA. No registration needed.

what

AIDA related news

en

AIDA at ESMO GI Congress and DiCE’s Masterclass

AIDA proudly participated in the ESMO Gastrointestinal Cancers Congress and the Digestive Cancers Europe Masterclass, joining leading clinicians, researchers, and patient advocates to discuss the future of digestive cancer prevention.

en

AIDA Partner LU KPMI Represents Europe at HUG 2025 in Seoul

From 20–22 March, AIDA partner LU KPMI (University of Latvia) participated in the HUG 2025 Symposium in Seoul, South Korea, one of the leading international meetings focused on Helicobacter pylori and upper gastrointestinal diseases.